Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

Alberta Health services70 enrolled

Overview

When colon or rectal cancer has spread to the liver, the cancer in the liver can sometimes be removed surgically. However, the cancer has a chance or reoccurring in the liver or elsewhere in the body. This study will determine if giving chemotherapy treatment before the surgery can reduce the chances that the cancer will come back.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Colorectal Adenocarcinoma Liver Metastases

Interventions

perioperative chemotherapyDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * stage IV colorectal cancer isolated to the liver * one measurable lesion * metastases are completely resectable or amenable to ablation * Karnofsky \>70 * Adequate bone marrow function * adequate hepatic function * adequate renal function * informed consent Exclusion Criteria: * primary tumor not controlled by locoregional treatments * bilateral portal vein and/or hepatic artery involvement * previous chemotherapy directed at treatment of metastatic colorectal cancer * underlying acute or chronic liver disease * Gilbert's disease * patients receiving phenytoin or phenobarbital prophylaxis * presence of any concurrent medical or psychiatric condition that serves as a contraindication to surgery or chemotherapy * pregnancy * malignancy other than basal cell or squamous cell carcinoma of the skin within the preceding 5 years * use of another investigational medication concurrently or within 4 months of enrollment

Locations (1)

Tom Baker Cancer Centre

Calgary, Alberta, Canada

Outcomes

Primary Outcomes

disease free survival

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.